Finding lung cancer at its earliest stages, when there is still the chance of a cure, is a problem. Regular CT scans can detect such cancers in older smokers who’ve smoked the equivalent of a pack a day for 30 years.

More black women die from breast cancer than white women each year. They also tend to be diagnosed with more aggressive forms of the disease. And clinicians blamed the higher death rates on these less treatable types of breast cancer.

In late February, the US Food and Drug Administration approved a new medication to treat HER2-positive breast cancer. The medication works by zeroing in on the HER2 proteins and then blasting them with a powerful chemotherapy agent.

Scientists have entered a brave new world when it comes to treating childhood leukemia. New therapies now being tested may completely change the way one type of blood cancer is treated in children.

The risk of breast cancer can be such that women may have both breasts removed to avoid the possibility. Would genetic testing affect this decision?

Surgery to remove brain tumors is a delicate business. In addition to removing the cancer, surgeons must be careful not to damage healthy tissue linked to function. A brain mapping technology may help ease this difficulty.

One day after announcing that his cancer had returned, Roger Ebert has died. The  veteran film critic for the Chicago Sun-Times had battled thyroid and salivary gland cancer for years. He was 70 years old.

Huge advances have been made in the understanding of multiple myeloma. There are a variety of approaches for treating this blood cancer. The trick is to provide what’s best for the individual patient.

Men with advanced prostate cancer usually take medicines to keep the disease at bay. These medications block male hormones that feed the cancer. New research evaluated the best way to take these medications.

Lynch syndrome is the most common genetic condition that’s linked to cancer.  While it is fairly rare, the condition can raise the risk for various cancers. But the connection between Lynch syndrome and prostate cancer has been uncertain.